Parkinson's disease (PD) is the second most common neurodegenerative disorder in the United States, which requires ongoing medication therapy. Despite the high prevalence of complementary health approaches (CHA) being used among people with PD in several countries, little is known about the perceived effectiveness, safety, and risk related to use of CHA. The purpose of this study was to describe CHA users' beliefs about the effectiveness, safety, and risk of CHA. A subsample (n = 70) of participants who reported using CHA and who completed all 12 items of the section of participants' beliefs were taken from a larger study (n = 143) that described the proportion of individuals who used CHA to manage PD symptoms. Participants reported that CHAs are somewhat effective to control or manage PD symptoms and necessary for PD management. However, they disagreed on possible adverse effects of CHAs and their potential interactions with prescription medications. Participants were willing to share their CHA use with their doctors and/or nurses and had a neutral response to the costs of CHA. More scientific evidence on effectiveness and safety/risk of CHA is needed to assist individuals' informed decision about using CHA and allocation of their health care spending. Nurses and other health care professionals need to be aware of CHA users' beliefs about CHA used for PD and of the need for provision of adequate information and resources, including locating qualified CHA practitioners or databases of CHA. Parkinson's disease (PD) is the second most common neurodegenerative disorder, which is prevalent among older adults in the United States.
Parkinson's disease (PD) is the second most common neurodegenerative disorder, which is prevalent among older adults in the United States. 1 People with PD experience a wide range of motor and nonmotor symptoms, which often interfere with individuals' optimal function and activities of daily living. 2, 3 Despite the essential role of pharmacological therapy in PD management, long-term use of pharmacological therapy often yields adverse reactions such as motor fluctuation and dyskinesia.
A holistic model in PD management proposed a need to incorporate a biopsychosocial-spiritual concept into health care. 6(p257) In the model, various types of complementary health approaches (CHAs) were addressed along with traditional medicine, including mind-body interventions, manual healing methods, diet/nutrition, and biologic treatments. Most of those therapies were part of complementary health approaches (CHA; formerly complementary and alternative medicine). CHA is a new term adopted by the National Center for Complementary and Integrative Health (NCCIH), which includes "a group of diverse medical and health care systems, practices, and products that are not considered to be part of conventional or allopathic medicine." 7(p6) Although use of CHA as part of self-management among people with PD in several countries has been reported in the literature, 8, 9 there is limited evidence about CHA users' perceived effectiveness, safety, and risk related to use of CHA. Lökk and Nilsson 4-point Likert-type question. The majority of the CHA users in the study perceived no or some improvement. In a study in Singapore, 40% of complementary therapy users reported some degree of improvement in their PD whereas 58% reported no improvement.
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Some CHA users also reported adverse reactions such as nausea and vomiting, limitation of limb movement after chiropractic treatment, aggravation of PD symptoms, and severe dyskinesia. 12 Participants who had used CHA discussed their concerns about risks associated with using CHA such as side effects of invasive methods (eg, acupuncture) and qualification of CHA practitioners. 13 Lökk and Nilsson 10 suggested that CHA users were influenced by their belief in CHA rather than by the perceived effect of CHA, and they were more prone to try CHA in the future. Thus, further research is needed to provide a better understanding on beliefs about the specific CHA used among CHA users living with PD.
This study was influenced by the holistic model of PD management 6 and the literature review on beliefs about CHA use in PD. The purpose of this study was to describe CHA users' beliefs about the effectiveness, safety, and risk of CHA for PD.
METHODS
This study used a subsample from a larger research project. Its aim was to quantify the proportion of community-dwelling participants with PD who used CHA, and what they were using CHA for. 9 Those who reported using CHA in the past 12 months were asked additional questions about their CHA beliefs. Only those who completed all 12 questions on beliefs about CHA were included. Twelve items regarding beliefs about CHA were developed by the researchers and reviewed by a group of PD experts and 3 people with PD ( Figure) . IBM SPSS Statistics version 23 was used to analyze the data from the survey. After data were screened for missingness, descriptive statistics, including frequencies and percentages for categorical data, were used to describe participant characteristics, types of CHA used, and participants' beliefs about CHA. Means and standard deviations (SD) were used for continuous data.
Procedures
Institutional review board approval was obtained from the researchers' institution, and informed consent was obtained from all participants with the survey. The data were collected from March 2015 to February 2016 using a mailed survey, which was developed by the researchers and validated by a group of experts. The survey included sociodemographic questions (eg, age, sex, race/ethnicity, marital status, years of education, household annual income, and health care spending/costs per month), disease-specific questions (eg, duration of PD, age at onset, motor and nonmotor symptoms, PD treatments, and other non-PD health-related issues), and questions on use of CHA (eg, previous and current use of CHA, in particular reasons for use of CHA, and beliefs about CHA). A section on the participant's beliefs about CHA I know what to look for in any side-and/or adverse effects of CHA that I used.
CHA may have interactions with my prescription medications.
I am not worried about side-and/or adverse effects of CHA.
CHA may give me side-and/or adverse effects.
I would recommend CHA to people with PD.
CHA are necessary for my PD management.
CHA are necessary for my general health.
CHA are effective to control or manage my PD non-motor symptoms.
CHA are effective to control or manage my PD motor symptoms. included 12 items: satisfaction of PD management, effectiveness, necessity, side and adverse effects, cost of CHA, and willingness to share their usage of CHA with health care professionals (see the Figure) . Participants were asked to share their beliefs based on a 6-point Likert-type scale (1 = strongly disagree, 2 = disagree, 3 = somewhat disagree, 4 = somewhat agree, 5 = agree, and 6 = strongly agree).
RESULTS

Characteristics of the participants
A subsample (n = 70) of participants who reported using CHA and who completed all 12 items of the section of participants' beliefs were taken from a larger study (n = 143) that described the proportion of individuals who use CHA to manage PD symptoms. More than half (54.3%) of the participants were males ( (SD = 2.93), had been diagnosed for 6.73 years (SD = 5.52), and had 13.2 (SD = 5.56) out of possible 32 symptoms. All participants were taking at least 1 medication for their PD (mean = 2.04, SD = 1.03) and used at least 1 CHA (mean = 10.04, SD = 9.49) within the last 12 months. The CHA used by the participants included natural products and mind and body approaches. Top 8 supplements and modalities were presented in Table 2 . Vitamins (eg, multivitamins, vitamins B 12 , C, and E), coconut oil, and coenzyme Q10 were commonly used natural products. Commonly used mind and body approaches included various types of exercise, yoga, massage, deep breathing exercises, prayer, meditation, tai chi, and acupuncture.
Beliefs about CHA
The mean satisfaction of current PD symptom management on a scale from 1 to 6 was 4.39 (SD = 1.08), indicating that on average people were more satisfied than not with their management (Figure) . Participants reported that they believed CHA was somewhat effective in helping to control or manage their PD motor symptoms (mean 
DISCUSSION
There were some limitations in this study. Participants were from a small, homogenous sample, which prevents a generalization of findings beyond this sample. Findings were based on self-reports, so it might be affected by participants' recall bias or their inclination to share socially desirable answers. The questions in the survey were developed by the researchers to explore the general understanding of CHA users' belief about PD. Findings of this study were not intended to explain the various types of CHA used in PD. Thus, this would need to be addressed in future studies. Findings of this study showed several inconsistencies with those of previous studies about perceived effectiveness of CHA among people with PD. Participants in this study believed that CHAs were effective to manage PD symptoms and necessary for general health and PD management. However, it is hard to measure how effective those CHAs were in managing PD symptoms, as participants took at least 1 PD medication and were in different stages of PD. Their responses might have been based purely on their satisfaction level of current PD management, impacting their beliefs about effectiveness of the CHA they had used. In addition, a previous study found that CHA users did not communicate with their health care providers about their usage of CHA.
14 In contrast, participants in this study reported that they were willing to share their usage of CHA with their health care professionals (eg, doctors and nurses). They also showed their willingness to recommend CHA they have used to others. It could be that they may have received referrals from their health care professionals or they intended to share all available information with their health care professionals to achieve optimal care.
Previous studies did not fully address CHA users' beliefs about safety and possible risks of CHA; however, there was 1 finding about management of safety and risks associated with usage of CHA in participants in a qualitative study. 13 Participants' approach to managing risks was to seek information by asking their nurses about potential risks from CHA (eg, acupuncture) and to check CHA practitioners' qualifications before initiation of CHA. Despite their knowledge of possible side and/or adverse effects of CHA, participants in this study did not agree on the possible side and/or adverse effects of CHA and interactions with their prescription medications. Of note, the question did not specify side and/or adverse effects of specific types of CHA used and frequency of use.
Participants had a neutral response to the costs of CHA, which was inconsistent with a previous finding that cost of CHA was a reason why some people did not use CHA. 10 However, the question of cost of CHA needs to be elaborated on in future studies, as specific costs of CHA used were not addressed in this study.
Findings of this study have implications for future research and holistic nursing practice. Given the limited information about scientific evidence on various types of CHA, 15 future studies are needed as follows. More scientific evidence on effectiveness and safety/risk of some types of CHA (eg, coconut oil) is needed to assist individuals' informed decision about using CHA and allocation of their health care spending. In addition, expanding health care coverage of evidence-based CHA could help people with limited, fixed income in using those CHAs along with conventional PD treatments. Nurses and other health care professionals need to be aware of CHA users' beliefs about CHA used for PD and of the need for provision of adequate information and resources, including locating qualified CHA practitioners or databases of CHA (eg, NCCIH Web site).
In conclusion, participants in this study believed that CHAs were effective to manage PD symptoms and necessary for general health and PD management. Thus, a holistic approach should be incorporated into PD management. Future research is needed to establish scientific evidence on specific types of CHA to ensure safe and effective CHA use in PD.
